225 件 ・ 関連度順
概要と使いどころ
Configure secure OAuth 2.0 authorization flows including Authorization Code with PKCE, Client Credentials, and Device Authorization Grant. This skill covers flow selection, PKCE implementation, token
日本語の概要は準備中です。原文の説明を表示しています。
Parse Office 365 Unified Audit Logs via Microsoft Graph API to detect email forwarding rule creation, inbox delegation, suspicious OAuth app grants, and other indicators of account compromise.
日本語の概要は準備中です。原文の説明を表示しています。
Review framework vs host ownership for permissions, approvals, grants, native execution, storage, daemons, and Clawix integration.
日本語の概要は準備中です。原文の説明を表示しています。
Signpost (not a knowledge pack) for the functional safety standards landscape: IEC 61508, ISO 26262, ISO/SAE 21434, UL 4600, SAE J3016, and ASPICE. Contains NO source content: designation, edition, owner, status, and an official catalogue URL only. Use when you need to identify or locate a functional safety standard. All six are paywalled or carry no redistribution grant and cannot be packaged; open paths point at US Government packs, which are not equivalents.
日本語の概要は準備中です。原文の説明を表示しています。
Signpost (not a knowledge pack) for the automotive standards landscape: ISO 26262, ASPICE, SAE J3016, UNECE R155, UNECE R156, and the NHTSA vehicle set. Contains NO source content: designation, edition, owner, status, and an official catalogue URL only. Use when you need to identify or locate an automotive standard. Most are paywalled or carry no redistribution grant and cannot be packaged; the one open path is the nhtsa-vehicle pack.
日本語の概要は準備中です。原文の説明を表示しています。
Turns an access export (accounts, entitlements, grant and last-used dates per system) into a draft access review pack, one section per system owner: who has what, since when, anomalies to confirm and the decision each line needs, with a blank column for the owner's decision. Never decides, revokes or rates access. Use when the user asks to "prepare the access review pack", "split this entitlement export by system owner", "who has access to what in this system", "build the recertification pack from this export" or "draft the access attestation for the owners". Do not use for a single request for a tool or access, use software-request-review instead. Drafts for human review; never approves, authorises or signs off.
日本語の概要は準備中です。原文の説明を表示しています。
Build, deploy, and maintain applications on Hugging Face Spaces — Gradio / Docker / Static SDKs, ZeroGPU and dedicated hardware, model loading, debugging, buckets, inference providers, community grants. Use whenever the user asks to create or host an app on Hugging Face, port code onto ZeroGPU, fix a Space that won't build or run, or otherwise work with `hf spaces …`, `@spaces.GPU`, Space README frontmatter, or the `spaces` Python package.
日本語の概要は準備中です。原文の説明を表示しています。
Use when designing, running, or judging an experiment on a Syntropic137 workflow - comparing prompt variants, fan-out vs single agent, adversarial cross-model review, model selection (can Haiku do this job), phase splits, or tool grants. Trigger phrases include "run a workflow experiment", "A/B the workflow", "does fan-out help", "which model for this phase", "is this prompt better", "measure review quality", "why did the workflow do that". Do NOT use for a one-off workflow run that is just doing work, for authoring a workflow that is not being compared against anything, or for debugging a single failed execution (that is ordinary debugging).
日本語の概要は準備中です。原文の説明を表示しています。
Parse Office 365 Unified Audit Logs via Microsoft Graph API to tespit etmeemail forwarding rule creation, inbox delegation, suspicious OAuth app grants, and other indicators of account compromise.
日本語の概要は準備中です。原文の説明を表示しています。
Configure secure OAuth 2.0 authorization flows including Authorization Code with PKCE, Client Credentials, and Device Authorization Grant. This skill covers flow selection, PKCE implementation, token
日本語の概要は準備中です。原文の説明を表示しています。
Parse Office 365 Unified Audit Logs via Microsoft Graph API to detect email forwarding rule creation, inbox delegation, suspicious OAuth app grants, and other indicators of account compromise.
日本語の概要は準備中です。原文の説明を表示しています。
Estimates the minimum biological replicates (or cells/events) for a target power at a target FDR in genomics experiments using ssizeRNA, PROPER, powsimR for scRNA-seq, and pilot-data dispersion estimation from DESeq2/edgeR. Covers the biological-versus-technical replication distinction (technical replicates do not add degrees of freedom for biological inference), replicate-number-versus-sequencing-depth budgeting, scRNA-seq sample-versus-cell allocation under a pseudobulk model, and the critique that "n=3" is a publication convention rather than a power calculation. Use when budgeting a sequencing experiment, writing the sample-size justification in a grant, estimating replicates from pilot data, allocating a fixed budget between samples and depth, or planning scRNA-seq cohort size. For clinical-trial sample size see clinical-biostatistics/power-and-sample-size; for the power-given-n direction see experimental-design/power-analysis.
日本語の概要は準備中です。原文の説明を表示しています。
Calculates statistical power for high-dimensional genomics experiments (bulk RNA-seq, scRNA-seq, ATAC-seq, ChIP-seq, methylation, proteomics) under negative-binomial count models using RNASeqPower, PROPER, and simulation via powsimR, distinguishing per-gene from marginal (transcriptome-wide) power, the role of mean expression and dispersion, and the sequencing-depth-versus-replicate tradeoff. Covers simulation as the honest default for overdispersed counts, FDR-aware average power versus single-test power, observed/post-hoc power as an anti-pattern, and the winner's-curse / Type-S / Type-M consequences of underpowering. Use when planning replicate number for a sequencing experiment, deciding whether to add depth or samples, choosing closed-form versus simulation power, estimating power from pilot dispersions, or justifying replication in a grant. For clinical-trial power see clinical-biostatistics/power-and-sample-size; for the inverse sample-size question see experimental-design/sample-size.
日本語の概要は準備中です。原文の説明を表示しています。
Check whether a user may start side work alongside their current job, by reading the employer's own rules and contract clause by clause: whether side work is prohibited, needs prior permission, or only a notification, and which duties the planned side work could touch (non-compete, confidentiality, exclusive attention to the main job, use of company assets and information, combined working hours). Separate what is confirmed in a document from what is hearsay, and produce the questions to ask the employer plus the facts an application or notification will need. Use when someone with a main job is considering side work, freelance or gyomu-itaku work, a second part-time job, or paid trial work for another company, and needs to know what their own employer's rules require first; do not use to rule on whether a clause is lawful or enforceable, to help conceal side work from an employer or avoid filing obligations, to predict whether permission will be granted, or to submit the application or contact the employer.
日本語の概要は準備中です。原文の説明を表示しています。
Estimates the minimum biological replicates (or cells/events) for a target power at a target FDR in genomics experiments using ssizeRNA, PROPER, powsimR for scRNA-seq, and pilot-data dispersion estimation from DESeq2/edgeR. Covers the biological-versus-technical replication distinction (technical replicates do not add degrees of freedom for biological inference), replicate-number-versus-sequencing-depth budgeting, scRNA-seq sample-versus-cell allocation under a pseudobulk model, and the critique that "n=3" is a publication convention rather than a power calculation. Use when budgeting a sequencing experiment, writing the sample-size justification in a grant, estimating replicates from pilot data, allocating a fixed budget between samples and depth, or planning scRNA-seq cohort size. For clinical-trial sample size see clinical-biostatistics/power-and-sample-size; for the power-given-n direction see experimental-design/power-analysis.
日本語の概要は準備中です。原文の説明を表示しています。
Calculates statistical power for high-dimensional genomics experiments (bulk RNA-seq, scRNA-seq, ATAC-seq, ChIP-seq, methylation, proteomics) under negative-binomial count models using RNASeqPower, PROPER, and simulation via powsimR, distinguishing per-gene from marginal (transcriptome-wide) power, the role of mean expression and dispersion, and the sequencing-depth-versus-replicate tradeoff. Covers simulation as the honest default for overdispersed counts, FDR-aware average power versus single-test power, observed/post-hoc power as an anti-pattern, and the winner's-curse / Type-S / Type-M consequences of underpowering. Use when planning replicate number for a sequencing experiment, deciding whether to add depth or samples, choosing closed-form versus simulation power, estimating power from pilot dispersions, or justifying replication in a grant. For clinical-trial power see clinical-biostatistics/power-and-sample-size; for the inverse sample-size question see experimental-design/sample-size.
日本語の概要は準備中です。原文の説明を表示しています。
Estimates the minimum biological replicates (or cells/events) for a target power at a target FDR in genomics experiments using ssizeRNA, PROPER, powsimR for scRNA-seq, and pilot-data dispersion estimation from DESeq2/edgeR. Covers the biological-versus-technical replication distinction (technical replicates do not add degrees of freedom for biological inference), replicate-number-versus-sequencing-depth budgeting, scRNA-seq sample-versus-cell allocation under a pseudobulk model, and the critique that "n=3" is a publication convention rather than a power calculation. Use when budgeting a sequencing experiment, writing the sample-size justification in a grant, estimating replicates from pilot data, allocating a fixed budget between samples and depth, or planning scRNA-seq cohort size. For clinical-trial sample size see clinical-biostatistics/power-and-sample-size; for the power-given-n direction see experimental-design/power-analysis.
日本語の概要は準備中です。原文の説明を表示しています。
Calculates statistical power for high-dimensional genomics experiments (bulk RNA-seq, scRNA-seq, ATAC-seq, ChIP-seq, methylation, proteomics) under negative-binomial count models using RNASeqPower, PROPER, and simulation via powsimR, distinguishing per-gene from marginal (transcriptome-wide) power, the role of mean expression and dispersion, and the sequencing-depth-versus-replicate tradeoff. Covers simulation as the honest default for overdispersed counts, FDR-aware average power versus single-test power, observed/post-hoc power as an anti-pattern, and the winner's-curse / Type-S / Type-M consequences of underpowering. Use when planning replicate number for a sequencing experiment, deciding whether to add depth or samples, choosing closed-form versus simulation power, estimating power from pilot dispersions, or justifying replication in a grant. For clinical-trial power see clinical-biostatistics/power-and-sample-size; for the inverse sample-size question see experimental-design/sample-size.
日本語の概要は準備中です。原文の説明を表示しています。
Write competitive research proposals for NSF, NIH, DOE, and DARPA. Agency-specific formatting, review criteria, budget preparation, broader impacts, significance statements, innovation narratives, and compliance with submission requirements.
日本語の概要は準備中です。原文の説明を表示しています。
Passthrough proxy for direct access to third-party APIs using managed OAuth connections, provided by [Maton](https://maton.ai). The API gateway lets y Connect to 100+ APIs (Google Workspace, Microsoft 365, GitHub, Notion, Slack, Airtable, HubSpot, etc.) with managed OAuth. Use this skill when users want to interact with external services. Security: The MATON_API_KEY authenticates with Maton.ai but grants NO access to third-party services by itself. Each service requires explicit OAuth authorization by the user through Maton's connect flow. Access is strictly scoped to connections the user has authorized. Provided by Maton (https://maton.ai).
日本語の概要は準備中です。原文の説明を表示しています。
Configure secure OAuth 2.0 authorization flows including Authorization Code with PKCE, Client Credentials, and Device Authorization Grant. This skill covers flow selection, PKCE implementation, token
日本語の概要は準備中です。原文の説明を表示しています。
Parse Office 365 Unified Audit Logs via Microsoft Graph API to detect email forwarding rule creation, inbox delegation, suspicious OAuth app grants, and other indicators of account compromise.
日本語の概要は準備中です。原文の説明を表示しています。
Use when a research proposal needs work packages, milestones, deliverables, a timeline, a risk register, and budget-justification scaffolding, while keeping scientific claims and feasibility honest and human-owned.
日本語の概要は準備中です。原文の説明を表示しています。
Hunt JWT cryptographic failures — alg:none signature-stripping and RS256→HS256 key-confusion that let an attacker forge a token for any identity (e.g. an admin) without knowing a secret. Use when the app authenticates with a JSON Web Token (an `eyJ...` Bearer token in the Authorization header, a cookie, or a login response). This skill OWNS JWT signature/crypto forgery (alg:none, key confusion, kid/jku header injection); hunt-ato covers JWT as one ATO path, hunt-auth-bypass covers SSO/SAML token trust, hunt-api-misconfig covers non-crypto JWT handling. Critical when a forged token grants access to another user's data or an admin-only endpoint.
日本語の概要は準備中です。原文の説明を表示しています。